Preventing and managing dry eyes after periorbital surgery

A retrospective review

Adam H. Hamawy, Jordan P. Farkas, Steven Fagien, Rod J. Rohrich

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

BACKGROUND: Dry eye syndrome is a common sequela associated with periorbital surgery. As more patients seek periorbital rejuvenation, understanding the pathophysiology, diagnosis, and treatment of this condition perioperatively is essential for managing patient expectations and maximizing outcomes. METHODS: A retrospective review of charts for 202 consecutive patients (180 women and 22 men) who underwent upper and/or lower blepharoplasty was performed. Additional facial cosmetic procedures were performed in 91 percent of patients. Data were collected identifying associated risk factors and the incidence of persistent dry eye symptoms. Key elements of perioperative care are described and algorithms for detection of those at risk, prevention, and management are outlined. RESULTS: Dry eyes persisting longer than 2 weeks after surgery were noted in 22 patients (10.9 percent) and longer than 2 months in only four patients (2 percent). In most cases, dry eyes resolved with conservative management, including artificial tears, lubrication, topical and systemic steroids, and night taping. One patient (0.5 percent of all studied patients) eventually needed surgical correction of lower eyelid retraction after failure of the punctate plug. Persistent chemosis occurred in 15 patients (68.2 percent) who had symptomatic dry eyes (p < 0.01). CONCLUSION: Recognizing and addressing risk factors before surgery and an algorithmic approach to prevention and management of patients undergoing periorbital surgery are essential for minimizing the occurrence of dry eye syndrome.

Original languageEnglish (US)
Pages (from-to)353-359
Number of pages7
JournalPlastic and Reconstructive Surgery
Volume123
Issue number1
DOIs
StatePublished - Jan 2009

Fingerprint

Dry Eye Syndromes
Blepharoplasty
Lubrication
Perioperative Care
Rejuvenation
Risk Management
Eyelids
Cosmetics
Steroids
Incidence
Therapeutics

ASJC Scopus subject areas

  • Surgery

Cite this

Preventing and managing dry eyes after periorbital surgery : A retrospective review. / Hamawy, Adam H.; Farkas, Jordan P.; Fagien, Steven; Rohrich, Rod J.

In: Plastic and Reconstructive Surgery, Vol. 123, No. 1, 01.2009, p. 353-359.

Research output: Contribution to journalArticle

Hamawy, Adam H. ; Farkas, Jordan P. ; Fagien, Steven ; Rohrich, Rod J. / Preventing and managing dry eyes after periorbital surgery : A retrospective review. In: Plastic and Reconstructive Surgery. 2009 ; Vol. 123, No. 1. pp. 353-359.
@article{344ce68d1c9e4d2db2950f9429c62107,
title = "Preventing and managing dry eyes after periorbital surgery: A retrospective review",
abstract = "BACKGROUND: Dry eye syndrome is a common sequela associated with periorbital surgery. As more patients seek periorbital rejuvenation, understanding the pathophysiology, diagnosis, and treatment of this condition perioperatively is essential for managing patient expectations and maximizing outcomes. METHODS: A retrospective review of charts for 202 consecutive patients (180 women and 22 men) who underwent upper and/or lower blepharoplasty was performed. Additional facial cosmetic procedures were performed in 91 percent of patients. Data were collected identifying associated risk factors and the incidence of persistent dry eye symptoms. Key elements of perioperative care are described and algorithms for detection of those at risk, prevention, and management are outlined. RESULTS: Dry eyes persisting longer than 2 weeks after surgery were noted in 22 patients (10.9 percent) and longer than 2 months in only four patients (2 percent). In most cases, dry eyes resolved with conservative management, including artificial tears, lubrication, topical and systemic steroids, and night taping. One patient (0.5 percent of all studied patients) eventually needed surgical correction of lower eyelid retraction after failure of the punctate plug. Persistent chemosis occurred in 15 patients (68.2 percent) who had symptomatic dry eyes (p < 0.01). CONCLUSION: Recognizing and addressing risk factors before surgery and an algorithmic approach to prevention and management of patients undergoing periorbital surgery are essential for minimizing the occurrence of dry eye syndrome.",
author = "Hamawy, {Adam H.} and Farkas, {Jordan P.} and Steven Fagien and Rohrich, {Rod J.}",
year = "2009",
month = "1",
doi = "10.1097/PRS.0b013e31819346ea",
language = "English (US)",
volume = "123",
pages = "353--359",
journal = "Plastic and Reconstructive Surgery",
issn = "0032-1052",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Preventing and managing dry eyes after periorbital surgery

T2 - A retrospective review

AU - Hamawy, Adam H.

AU - Farkas, Jordan P.

AU - Fagien, Steven

AU - Rohrich, Rod J.

PY - 2009/1

Y1 - 2009/1

N2 - BACKGROUND: Dry eye syndrome is a common sequela associated with periorbital surgery. As more patients seek periorbital rejuvenation, understanding the pathophysiology, diagnosis, and treatment of this condition perioperatively is essential for managing patient expectations and maximizing outcomes. METHODS: A retrospective review of charts for 202 consecutive patients (180 women and 22 men) who underwent upper and/or lower blepharoplasty was performed. Additional facial cosmetic procedures were performed in 91 percent of patients. Data were collected identifying associated risk factors and the incidence of persistent dry eye symptoms. Key elements of perioperative care are described and algorithms for detection of those at risk, prevention, and management are outlined. RESULTS: Dry eyes persisting longer than 2 weeks after surgery were noted in 22 patients (10.9 percent) and longer than 2 months in only four patients (2 percent). In most cases, dry eyes resolved with conservative management, including artificial tears, lubrication, topical and systemic steroids, and night taping. One patient (0.5 percent of all studied patients) eventually needed surgical correction of lower eyelid retraction after failure of the punctate plug. Persistent chemosis occurred in 15 patients (68.2 percent) who had symptomatic dry eyes (p < 0.01). CONCLUSION: Recognizing and addressing risk factors before surgery and an algorithmic approach to prevention and management of patients undergoing periorbital surgery are essential for minimizing the occurrence of dry eye syndrome.

AB - BACKGROUND: Dry eye syndrome is a common sequela associated with periorbital surgery. As more patients seek periorbital rejuvenation, understanding the pathophysiology, diagnosis, and treatment of this condition perioperatively is essential for managing patient expectations and maximizing outcomes. METHODS: A retrospective review of charts for 202 consecutive patients (180 women and 22 men) who underwent upper and/or lower blepharoplasty was performed. Additional facial cosmetic procedures were performed in 91 percent of patients. Data were collected identifying associated risk factors and the incidence of persistent dry eye symptoms. Key elements of perioperative care are described and algorithms for detection of those at risk, prevention, and management are outlined. RESULTS: Dry eyes persisting longer than 2 weeks after surgery were noted in 22 patients (10.9 percent) and longer than 2 months in only four patients (2 percent). In most cases, dry eyes resolved with conservative management, including artificial tears, lubrication, topical and systemic steroids, and night taping. One patient (0.5 percent of all studied patients) eventually needed surgical correction of lower eyelid retraction after failure of the punctate plug. Persistent chemosis occurred in 15 patients (68.2 percent) who had symptomatic dry eyes (p < 0.01). CONCLUSION: Recognizing and addressing risk factors before surgery and an algorithmic approach to prevention and management of patients undergoing periorbital surgery are essential for minimizing the occurrence of dry eye syndrome.

UR - http://www.scopus.com/inward/record.url?scp=60549107187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=60549107187&partnerID=8YFLogxK

U2 - 10.1097/PRS.0b013e31819346ea

DO - 10.1097/PRS.0b013e31819346ea

M3 - Article

VL - 123

SP - 353

EP - 359

JO - Plastic and Reconstructive Surgery

JF - Plastic and Reconstructive Surgery

SN - 0032-1052

IS - 1

ER -